/PRNewswire/ Med Learning Group ("MLG"), a leading provider of continuing medical education, announces its successful acquisition of Talem Health ("Talem"),.
Volrustomig demonstrated efficacy when used as frontline treatment in patients with clear cell renal cell carcinoma with a toxicity profile that is consistent with dual checkpoint inhibition.